Shaanxi Xianhe Biotech
Retatrutide
Finnrick tested 4 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Shaanxi Xianhe Biotech between 16 Jun 2026 and 12 Aug 2026. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).
Finnrick Rating™
Tentative Rating
Shaanxi Xianhe Biotech
Retatrutide
Tested 4 Samples
Last test 12 Aug 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Shaanxi Xianhe Biotech
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
12 Aug 2026
First
16 Jun 2026
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 12 Aug 2026 | View | 10mg | 10.1mg | +1.0% | 99.90% | 05-23-26 | No label / Silver crimp / Clear Green cap | Lab E | Public | |
| 9 Aug 2026 | View | 20mg | 22.8mg | +14.0% | 99.80% | 05-29-26 | No label / Silver crimp / Clear Blue cap | Lab G | Public | |
| 22 Jun 2026 | View | 20mg | ⚠️ Sample does not contain Retatrutide | 02-FEB-26 | No label / Silver crimp / Red cap | Lab E | Public | |||
| 16 Jun 2026 | View | 10mg | ⚠️ Sample does not contain Retatrutide | 10-FEB-26 | No label / Silver crimp / Red cap | Lab G | Public | |||